tiprankstipranks
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market
Want to see PBLA full AI Analyst Report?

Panbela Therapeutics (PBLA) Financial Statements

244 Followers

Panbela Therapeutics Financial Overview

Panbela Therapeutics's market cap is currently $53.89K. The company's EPS TTM is $; its P/E ratio is ―; Panbela Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -25.65M$ -35.73M$ -10.01M$ -5.75M$ -4.32M
Operating Income$ -51.29M$ -34.09M$ -10.01M$ -5.75M$ -4.32M
EBITDA$ -25.77M$ -34.74M$ -10.61M$ -4.93M$ -4.42M
Net Income$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Balance Sheet
Cash & Short-Term Investments$ 2.58M$ 1.28M$ 11.87M$ 9.02M$ 2.45M
Total Assets$ 11.80M$ 4.98M$ 12.87M$ 9.81M$ 3.14M
Total Debt$ 5.19M$ 6.84M-$ 0.00$ 116.00K
Net Debt$ 2.62M$ 5.56M$ -11.87M$ -9.02M$ -2.33M
Total Liabilities$ 16.51M$ 13.03M$ 2.66M$ 1.36M$ 1.76M
Stockholders' Equity$ -4.71M$ -8.05M$ 10.21M$ 8.45M$ 1.39M
Cash Flow
Free Cash Flow$ -25.25M$ -15.94M$ -6.70M$ -3.85M$ -2.74M
Operating Cash Flow$ -25.25M$ -15.28M$ -6.70M$ -3.85M$ -2.74M
Investing Cash Flow$ 400.00K$ -656.00K$ -540.00K$ 0.00$ 0.00
Financing Cash Flow$ 26.14M$ 5.35M$ 10.10M$ 10.44M$ 3.78M
Currency in USD

Panbela Therapeutics Earnings and Revenue History

Panbela Therapeutics Debt to Assets

Panbela Therapeutics Cash Flow

Panbela Therapeutics Forecast EPS vs Actual EPS